🔗 Share this article

An underground economy for unlicensed slimming medications is being driven by social media fitness personalities and vendors on communication apps, based on new investigations.

Experimental Treatment Gaining Traction Via Social Media

The experimental drug, which is still in clinical trials, is being advertised by online personalities for its alleged weight-reducing properties. Followers are encouraged to message these profiles directly for source information, while also receiving discount codes.

Active Commerce on Messaging Platforms

Additionally, a flourishing trade exists on messaging services, where communities with thousands of participants share comparison photos, injection guides and claims of next-day UK delivery. Sellers market the substance there before redirecting buyers to other platforms for transactions.

Learning About Retatrutide

This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.

Medical Experts Voice Worries

Nevertheless, physicians and pharmacists have warned that the sale of what remains an unlicensed medication in the United Kingdom is a cause for concern and could lead to individuals administering substances of unknown origin.

Several experts said the demand for the experimental drug could be connected to the rising cost of licensed slimming products such as Mounjaro.

Legal Position and Enforcement

Marketing the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still violate medicines, advertising, and customer regulations, potentially leading to fines, prosecution or imprisonment.

Platform Response and Material Removal

According to TikTok, the service has taken down problematic material and banned related keywords and query recommendations. The organization stated it was committed to keeping the service safe and allocating resources in enhancing enforcement strategies.

Digital Trading Activities

Investigations also discovered communities with up to 9,000 members selling retatrutide using Telegram's integrated search feature, which operates like a online catalog. Entering “retatrutide” immediately brings up groups with thousands of members, filled with photos of weight loss, glowing reviews and step-by-step instructions for mixing or administering at residence.

Within minutes of entering one community, a vendor shared WhatsApp details, where most purchases take place. The seller provided an guidebook and guaranteed shipping within 48 hours. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None inquired about weight, health issues or previous experience.

Item Details and Pricing

Within these groups, messages show black plastic parcels with postal service labels, stating to include new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at residence with sterile water, or ready-to-use pens usually priced at £160 for 20mg. When questioned how much time a injector should be used, vendors give conflicting responses ranging from a several days to “depends on your body”.

Service Moderation and Security Actions

A spokesperson for Telegram said it regularly moderated harmful content on its service including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are injecting materials they can’t verify. Even if the science behind this drug is sound, these online products may not contain what they advertise,” said a pharmacy expert, the head of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the increase in interest to current price rises for authorized slimming medications such as Mounjaro. “With costs increasing, individuals are using social media. But counterfeit injections are highly risky. You can’t be certain what’s inside or whether the environment they were made in was clean,” she explained.

Her staff has already encountered patients injured by self-injection from unconfirmed sources. “We recognize the frustration, but purchasing from Telegram or WhatsApp is gambling with your well-being,” stated Wyllie. “These materials could be impure or improperly measured.”

Producer Statement

A representative from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been reviewed or approved by any regulatory agency globally. “Therefore at this point no one can sell [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a company investigational product not yet approved … may expose users to possibly serious medical dangers”.